Sovereign Pharmaceuticals, LLC – Trademark Portfolio
Entity Type: 16
Sovereign Pharmaceuticals, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SOVEREIGN PHARMACEUTICALS. The owner is based in Ft. Worth, TX.
7590 Sand Street
Riverbend Business Park, Building # 15
Ft. Worth, TX 76118
Showing of trademarks Trademarks
Trademark Classifications
Sovereign Pharmaceuticals, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Sovereign Pharmaceuticals, LLC have?
Sovereign Pharmaceuticals, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does Sovereign Pharmaceuticals, LLC file in?
Sovereign Pharmaceuticals, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Sovereign Pharmaceuticals, LLC's most well-known trademarks?
Sovereign Pharmaceuticals, LLC's registered trademark portfolio includes well-known marks such as SOVEREIGN PHARMACEUTICALS. These are among 1 currently registered trademark in the portfolio.
What is Sovereign Pharmaceuticals, LLC's trademark registration success rate?
Sovereign Pharmaceuticals, LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.